1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. VIRACTA THERAPEUTICS INC
Viracta Therapeutics Inc XNAS: VIRX

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Viracta Therapeutics Inc is on 11 Sep 2025 for the purpose of Viracta Therapeutics Inc Second Quarter Earnings Results for 2025 See details


Insider Trading disclosures for Viracta Therapeutics Inc

The latest disclosure was made by Pomerantz J. Roger in Viracta Therapeutics Inc where a trade of 9,034 Restricted Stock Units done was reported to US exchanges on Nov. 25, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Pomerantz J. Roger Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Nov 2024 9,034 18,069 - - Restricted Stock Units
Ivor Royston Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Nov 2024 25,219 839,741 - 0 Common Stock
Roger J. Pomerantz Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Nov 2024 9,034 126,478 - 0 Common Stock
Royston Ivor Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Nov 2024 25,219 50,438 - - Restricted Stock Units
Ivor Royston Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Aug 2024 25,219 814,522 - 0 Common Stock
Ivor Royston Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Aug 2024 25,219 75,657 - - Restricted Stock Units
Roger J. Pomerantz Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Aug 2024 9,034 27,103 - - Restricted Stock Units
Roger J. Pomerantz Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Aug 2024 9,034 117,444 - 0 Common Stock
Ivor Royston Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 50,000 50,000 - - Stock Option (Right to Buy)
Thomas E. Darcy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 50,000 50,000 - - Stock Option (Right to Buy)
Roger J. Pomerantz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 50,000 50,000 - - Stock Option (Right to Buy)
Roger J. Pomerantz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 18,750 18,750 - - Stock Option (Right to Buy)
Barry J. Simon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 50,000 50,000 - - Stock Option (Right to Buy)
Jane F. Barlow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 50,000 50,000 - - Stock Option (Right to Buy)
Stephen Rubino Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 50,000 50,000 - - Stock Option (Right to Buy)
Flavia Borellini Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 50,000 50,000 - - Stock Option (Right to Buy)
Jane Chung Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 50,000 50,000 - - Stock Option (Right to Buy)
Ivor Royston Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 May 2024 25,219 789,303 - 0 Common Stock
Ivor Royston Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 May 2024 25,219 100,876 - - Restricted Stock Units
Roger J. Pomerantz Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 May 2024 9,035 36,137 - - Restricted Stock Units
Roger J. Pomerantz Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 May 2024 9,035 108,410 - 0 Common Stock
Mark Andrew Rothera Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2024 475,000 475,000 - - Stock Option (Right to Buy)
Daniel R. Chevallard CFO and COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2024 200,000 200,000 - - Stock Option (Right to Buy)
Darrel P. Cohen Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2024 120,000 120,000 - - Stock Option (Right to Buy)
Chevallard R. Daniel CFO and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Feb 2024 6,889 105,711 - 0 Common Stock
Royston Ivor Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Feb 2024 25,219 126,095 - - Restricted Stock Units
Roger J. Pomerantz Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Feb 2024 9,034 99,375 - 0 Common Stock
R. Daniel Chevallard CFO and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Feb 2024 6,889 34,444 - - Restricted Stock Units
R. Daniel Chevallard CFO and COO Sale of securities on an exchange or to another person at price $ 0.73 per share. 25 Feb 2024 3,405 102,306 - 0.7 2,493 Common Stock
Pomerantz J. Roger Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Feb 2024 9,034 45,172 - - Restricted Stock Units
Royston Ivor Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Feb 2024 25,219 764,084 - 0 Common Stock
Rothera Andrew Mark Director, President and CEO Purchase of securities on an exchange or from another person at price $ 0.49 per share. 30 Nov 2023 47,906 100,000 - 0.5 23,627 Common Stock
Rothera Mark Andrew Director, President and CEO Purchase of securities on an exchange or from another person at price $ 0.49 per share. 30 Nov 2023 52,094 52,094 - 0.5 25,734 Common Stock
Ivor Royston Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Aug 2023 25,219 176,533 - - Restricted Stock Units
Ivor Royston Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Aug 2023 25,219 713,646 - 0 Common Stock
Roger J. Pomerantz Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Aug 2023 9,034 81,307 - 0 Common Stock
Roger J. Pomerantz Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Aug 2023 9,034 63,240 - - Restricted Stock Units
Daniel R. Chevallard CFO and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Aug 2023 6,888 99,165 - 0 Common Stock
Daniel R. Chevallard CFO and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Aug 2023 6,888 48,222 - - Restricted Stock Units
Daniel R. Chevallard CFO and COO Sale of securities on an exchange or to another person at price $ 1.45 per share. 25 Aug 2023 3,512 95,653 - 1.4 5,092 Common Stock
Roger J. Pomerantz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Aug 2023 15,000 15,000 - - Stock Option (Right to Buy)
Darrel P. Cohen Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Aug 2023 235,000 235,000 - - Stock Option (Right to Buy)
Darrel P. Cohen Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Aug 2023 265,000 265,000 - - Stock Option (Right to Buy)
Ivor Royston Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 40,000 40,000 - - Stock Option (Right to Buy)
Thomas E. Darcy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 40,000 40,000 - - Stock Option (Right to Buy)
Roger J. Pomerantz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 40,000 40,000 - - Stock Option (Right to Buy)
Barry J. Simon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 40,000 40,000 - - Stock Option (Right to Buy)
Jane F. Barlow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 40,000 40,000 - - Stock Option (right to buy)
Stephen Rubino Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 40,000 40,000 - - Stock Option (Right to Buy)
Flavia Borellini Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 40,000 40,000 - - Stock Option (Right to Buy)
Jane Chung Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 40,000 40,000 - - Stock Option (Right to Buy)
Mark Andrew Rothera Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2023 400,000 400,000 - - Stock Option (Right to Buy)
Daniel R. Chevallard CFO and COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2023 200,000 200,000 - - Stock Option (Right to Buy)
Lisa Rojkjaer Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2023 150,000 150,000 - - Stock Option (Right to Buy)
Ivor Royston Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Feb 2023 25,219 663,208 - 0 Common Stock
Ivor Royston Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Feb 2023 25,219 226,971 - - Restricted Stock Units
Roger J. Pomerantz Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Feb 2023 9,034 81,309 - - Restricted Stock Units
Roger J. Pomerantz Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Feb 2023 9,034 63,238 - 0 Common Stock
Daniel R. Chevallard CFO and COO Sale of securities on an exchange or to another person at price $ 1.68 per share. 25 Feb 2023 3,599 89,023 - 1.7 6,051 Common Stock
Daniel R. Chevallard CFO and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Feb 2023 6,889 92,622 - 0 Common Stock
Daniel R. Chevallard CFO and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Feb 2023 6,889 61,999 - - Restricted Stock Units
Lisa Rojkjaer Chief Medical Officer Sale of securities on an exchange or to another person at price $ 1.68 per share. 25 Feb 2023 2,156 48,087 - 1.7 3,625 Common Stock
Lisa Rojkjaer Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Feb 2023 4,127 37,146 - - Restricted Stock Units
Lisa Rojkjaer Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Feb 2023 4,127 50,243 - 0 Common Stock
Ivor Royston Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Nov 2022 25,219 637,989 - 0 Common Stock
Ivor Royston Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Nov 2022 25,219 252,190 - - Restricted Stock Units
Roger J. Pomerantz Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Nov 2022 9,034 54,204 - 0 Common Stock
Roger J. Pomerantz Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Nov 2022 9,034 90,343 - - Restricted Stock Units
Daniel R. Chevallard CFO and COO Sale of securities on an exchange or to another person at price $ 2.72 per share. 25 Nov 2022 3,532 85,733 - 2.7 9,606 Common Stock
Daniel R. Chevallard CFO and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Nov 2022 6,889 89,265 - 0 Common Stock
Daniel R. Chevallard CFO and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Nov 2022 6,889 68,888 - - Restricted Stock Units
Lisa Rojkjaer Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Nov 2022 4,127 48,232 - 0 Common Stock
Lisa Rojkjaer Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Nov 2022 4,127 41,273 - - Restricted Stock Units
Lisa Rojkjaer Chief Medical Officer Sale of securities on an exchange or to another person at price $ 2.72 per share. 25 Nov 2022 2,116 46,116 - 2.7 5,754 Common Stock
Mark Andrew Rothera Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Sep 2022 1,375,000 1,375,000 - - Stock Option (Right to Buy)
Ivor Royston Director, CEO & President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Aug 2022 25,219 626,149 - 0 Common Stock
Ivor Royston Director, CEO & President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Aug 2022 25,219 277,409 - - Restricted Stock Units
Ivor Royston Director, CEO & President Sale of securities on an exchange or to another person at price $ 4.01 per share. 25 Aug 2022 13,379 612,770 - 4.0 53,656 Common Stock
Roger J. Pomerantz Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Aug 2022 9,034 45,170 - 0 Common Stock
Roger J. Pomerantz Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Aug 2022 9,034 99,377 - - Restricted Stock Units
Daniel R. Chevallard CFO and COO Sale of securities on an exchange or to another person at price $ 4.02 per share. 25 Aug 2022 3,655 82,376 - 4.0 14,679 Common Stock
Daniel R. Chevallard CFO and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Aug 2022 6,889 86,031 - 0 Common Stock
Daniel R. Chevallard CFO and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Aug 2022 6,889 75,777 - - Restricted Stock Units
Lisa Rojkjaer Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Aug 2022 4,127 45,400 - - Restricted Stock Units
Lisa Rojkjaer Chief Medical Officer Sale of securities on an exchange or to another person at price $ 4.01 per share. 25 Aug 2022 2,190 44,105 - 4.0 8,786 Common Stock
Lisa Rojkjaer Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Aug 2022 4,127 46,295 - 0 Common Stock
Roger J. Pomerantz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Aug 2022 30,282 30,282 - - Stock Option (Right to Buy)
Jane Chung Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Aug 2022 80,000 80,000 - - Stock Option (Right to Buy)
Thomas E. Darcy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 40,000 40,000 - - Stock Option (Right to Buy)
Nicole Onetto Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 40,000 40,000 - - Stock Option (Right to Buy)
Roger J. Pomerantz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 40,000 40,000 - - Stock Option (Right to Buy)
Barry J. Simon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 40,000 40,000 - - Stock Option (Right to Buy)
Jane F. Barlow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 40,000 40,000 - - Stock Option (right to buy)
Michael Huang Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 40,000 40,000 - - Stock Option (Right to Buy)
Stephen Rubino Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 40,000 40,000 - - Stock Option (Right to Buy)
Flavia Borellini Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 40,000 40,000 - - Stock Option (Right to Buy)
Ivor Royston Director, CEO & President Sale of securities on an exchange or to another person at price $ 1.90 per share. 25 May 2022 13,162 600,930 - 1.9 25,022 Common Stock
Ivor Royston Director, CEO & President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 May 2022 25,219 302,628 - - Restricted Stock Units
Ivor Royston Director, CEO & President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 May 2022 25,219 614,092 - 0 Common Stock
Roger J. Pomerantz Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 May 2022 9,034 108,411 - - Restricted Stock Units
Roger J. Pomerantz Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 May 2022 9,034 36,136 - 0 Common Stock
Daniel R. Chevallard CFO and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 May 2022 6,889 82,666 - - Restricted Stock Units
Daniel R. Chevallard CFO and COO Sale of securities on an exchange or to another person at price $ 1.90 per share. 25 May 2022 3,596 79,142 - 1.9 6,836 Common Stock
Daniel R. Chevallard CFO and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 May 2022 6,889 82,738 - 0 Common Stock
Lisa Rojkjaer Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 May 2022 4,127 49,527 - - Restricted Stock Units
Lisa Rojkjaer Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 May 2022 4,127 44,322 - 0 Common Stock
Lisa Rojkjaer Chief Medical Officer Sale of securities on an exchange or to another person at price $ 1.90 per share. 25 May 2022 2,154 42,168 - 1.9 4,095 Common Stock
Ivor Royston Director, CEO & President Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2022 412,500 412,500 - - Stock Option (Right to Buy)
Daniel R. Chevallard CFO and COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2022 195,000 195,000 - - Stock Option (Right to Buy)
Lisa Rojkjaer Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2022 150,000 150,000 - - Stock Option (Right to Buy)
Ivor Royston Director, CEO & President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Feb 2022 25,219 603,508 - 0 Common Stock
Ivor Royston Director, CEO & President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Feb 2022 25,219 327,847 - - Restricted Stock Units
Ivor Royston Director, CEO & President Sale of securities on an exchange or to another person at price $ 2.78 per share. 25 Feb 2022 14,635 588,873 - 2.8 40,678 Common Stock
Roger J. Pomerantz Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Feb 2022 9,034 27,102 - 0 Common Stock
Roger J. Pomerantz Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Feb 2022 9,034 117,445 - - Restricted Stock Units
Daniel R. Chevallard CFO and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Feb 2022 6,889 89,555 - - Restricted Stock Units
Daniel R. Chevallard CFO and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Feb 2022 6,889 79,847 - 0 Common Stock
Daniel R. Chevallard CFO and COO Sale of securities on an exchange or to another person at price $ 2.78 per share. 25 Feb 2022 3,998 75,849 - 2.8 11,112 Common Stock
Lisa Rojkjaer Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Feb 2022 4,127 53,654 - - Restricted Stock Units
Lisa Rojkjaer Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Feb 2022 4,127 42,590 - 0 Common Stock
Lisa Rojkjaer Chief Medical Officer Sale of securities on an exchange or to another person at price $ 2.78 per share. 25 Feb 2022 2,395 40,195 - 2.8 6,657 Common Stock
Ivor Royston Director, CEO & President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.90 per share. 29 Dec 2021 7,000 578,289 - 0.9 6,300 Common Stock
Ivor Royston Director, CEO & President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Dec 2021 7,000 60,800 - - Stock Option (Right to Buy)
Ivor Royston Director, CEO & President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Nov 2021 50,437 599,036 - 0 Common Stock
Ivor Royston Director, CEO & President Sale of securities on an exchange or to another person at price $ 4.80 per share. 25 Nov 2021 11,914 587,122 - 4.8 57,194 Common Stock
Ivor Royston Director, CEO & President Sale of securities on an exchange or to another person at price $ 4.82 per share. 25 Nov 2021 15,833 571,289 - 4.8 76,301 Common Stock
Ivor Royston Director, CEO & President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Nov 2021 50,437 353,066 - - Restricted Stock Units
Roger J. Pomerantz Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Nov 2021 18,068 126,479 - - Restricted Stock Units
Roger J. Pomerantz Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Nov 2021 18,068 18,068 - 0 Common Stock
Daniel R. Chevallard CFO and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Nov 2021 13,777 96,444 - - Restricted Stock Units
Daniel R. Chevallard CFO and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Nov 2021 13,777 80,537 - 0 Common Stock
Daniel R. Chevallard CFO and COO Sale of securities on an exchange or to another person at price $ 4.80 per share. 25 Nov 2021 3,254 77,283 - 4.8 15,621 Common Stock
Daniel R. Chevallard CFO and COO Sale of securities on an exchange or to another person at price $ 4.82 per share. 25 Nov 2021 4,325 72,958 - 4.8 20,843 Common Stock
Lisa Rojkjaer Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Nov 2021 8,254 57,781 - - Restricted Stock Units
Lisa Rojkjaer Chief Medical Officer Sale of securities on an exchange or to another person at price $ 4.82 per share. 25 Nov 2021 2,591 38,463 - 4.8 12,486 Common Stock
Lisa Rojkjaer Chief Medical Officer Sale of securities on an exchange or to another person at price $ 4.80 per share. 25 Nov 2021 1,950 41,054 - 4.8 9,361 Common Stock
Lisa Rojkjaer Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Nov 2021 8,254 43,004 - 0 Common Stock
Ivor Royston Director, CEO & President Purchase of securities on an exchange or from another person at price $ 5.56 per share. 15 Nov 2021 8,000 548,599 - 5.6 44,480 Common Stock
Daniel R. Chevallard CFO and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.90 per share. 28 Sep 2021 10,000 66,760 - 0.9 9,000 Common Stock
Daniel R. Chevallard CFO and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Sep 2021 10,000 88,817 - - Stock Option (Right to Buy)
Jane F. Barlow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Aug 2021 80,000 80,000 - - Stock Option (Right to Buy)
Flavia Borellini Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Aug 2021 80,000 80,000 - - Stock Option (Right to Buy)
Daniel R. Chevallard CFO and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.90 per share. 28 May 2021 12,000 56,760 - 0.9 10,800 Common Stock
Daniel R. Chevallard CFO and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 May 2021 12,000 98,817 - - Stock Option (Right to Buy)
Lisa Rojkjaer Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.58 per share. 11 May 2021 2,061 34,750 - 3.6 7,378 Common Stock
Lisa Rojkjaer Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.26 per share. 11 May 2021 32,689 32,689 - 1.3 41,188 Common Stock
Lisa Rojkjaer Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 May 2021 32,689 98,069 - - Stock Option (Right to Buy)
Lisa Rojkjaer Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 May 2021 2,061 30,956 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters